Company Filing History:
Years Active: 2008-2013
Title: The Innovations of Christopher C Glenn: A Pioneer in West Nile Virus Detection
Introduction
Christopher C Glenn, based in Holly Springs, North Carolina, is an accomplished inventor with a focus on the detection of the West Nile virus. With a total of three patents to his name, Glenn has made significant contributions to medical diagnostics, specifically in the field of virology.
Latest Patents
Among his latest innovations, Glenn holds patents for "Oligonucleotides and Methods for Detection of West Nile Virus." This invention encompasses methods and oligonucleotide reagents derived from a West Nile virus consensus sequence, which are crucial in the timely and accurate detection of the virus. The significance of these patents lies in their potential to enhance public health responses to West Nile virus outbreaks.
Career Highlights
Christopher C Glenn is employed at Bayer Healthcare LLC, a company that is well-recognized for its commitment to health advancements and innovative pharmaceutical development. His role allows him to work at the intersection of research and practical application, ensuring that his inventions can make a real difference in diagnosing and preventing viral infections.
Collaborations
Throughout his career, Glenn has collaborated with notable colleagues, including Stefan H M Burde and Todd M Gierman. Their collective expertise plays a vital role in advancing the research and application of methods related to viral detection, contributing to the broader efforts in public health.
Conclusion
Christopher C Glenn exemplifies the spirit of innovation through his dedication to enhancing detection methods for infectious diseases like the West Nile virus. His work at Bayer Healthcare LLC, in collaboration with talented peers, continues to pave the way for breakthroughs in medical diagnostics, ultimately benefiting global health initiatives.